UPI News Alert Uroplasty (UPI) 1.27 02/14/2015 09:21:47

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 10:21 AM

Uroplasty (UPI) 1.27 $UPI

INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Vision-Sciences, Inc. In Connection With the Fairness of the Merger of the Company to Uroplasty, Inc.
Business Wire - Mon Feb 02, 2:57PM CST
Levi & Korsinsky is commencing an investigation into the Board of Directors of Vision-Sciences, Inc. ("Vision-Sciences" or "the Company"

(NasdaqCM:VSCI) in connection with possible breaches of fiduciary duty and other violations of state law in connection with the merger of the Company to Uroplasty, Inc. (NasdaqCM:UPI).
VSCI: 0.47 (unch), UPI: 1.27 (unch)

Insider Trading Alert - MD, OKSB And UPI Traded By Insiders
at The Street - Mon Feb 02, 9:56AM CST
Stocks with insider trader activity include MD, OKSB and UPI
OKSB: 16.51 (+0.09), UPI: 1.27 (unch), MD: 71.32 (-0.06)

Nasdaq stocks posting largest volume increases
AP - Tue Jan 27, 5:09PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
BLVD: 9.73 (+0.04), HTBX: 5.83 (+0.22), GLBZ: 12.65 (+0.35), LSCC: 6.10 (+0.02), SAL: 28.70 (unch), CRDS: 2.32 (+0.05), WVFC: 11.02 (-0.45), CRRC: 22.96 (+0.22), AMRB: 9.59 (-0.06), NFEC: 2.11 (+0.02), STAA: 6.76 (-0.02), SIMG: 7.25 (-0.01), SBSI: 29.39 (-0.01), UPI: 1.27 (unch), RITT: 1.29 (unch)

Merger Arbitrage Mondays - January 26, 2015
Asif Suria - Seeking Alpha - Mon Jan 26, 8:33AM CST
Merger activity decreased last week with one new merger announced and two deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal Statistics: ...
GFIG: 6.03 (-0.03), TLM: 7.63 (-0.03), NWBI: 11.91 (+0.08), LO: 67.30 (-0.80), URZ: 1.18 (+0.01), BGCP: 9.34 (+0.19), UUUU: 4.93 (-0.02), T: 34.66 (+0.05), DLTR: 76.82 (+0.97), VSCI: 0.47 (unch), DTV: 87.51 (-0.32), UPI: 1.27 (unch), TWC: 149.74 (+2.21), BHI: 64.31 (+1.93), ESYS: 17.46 (+0.01), RAI: 71.86 (-1.23), LNN: 88.94 (-0.02), HAL: 44.19 (+1.42), EDS: 1.55 (+0.01), FDO: 77.86 (+0.31), CYN: 90.32 (+0.49), MRK: 58.81 (-0.07), RY: 62.26 (+0.23), LNBB: 17.74 (-0.01), IGT: 17.20 (-0.04), CMCSA: 59.47 (+1.09)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Jan 23, 11:46AM CST

AVP: 9.08 (+0.39), OCN: 9.10 (+0.09), TBIO: 2.91 (+0.01), RYAM: 17.58 (+0.36), VTAE: 14.40 (+0.82), FXCM: 2.21 (-0.01), ANR: 1.27 (+0.03), SNMX: 5.92 (+0.26), NVRO: 43.70 (+0.57), MHR: 2.62 (+0.11), EGLT: 10.60 (+0.58), SBS: 5.41 (+0.21), VGGL: 1.77 (-0.08), UPI: 1.27 (unch), TRLA: 46.89 (+0.74), HLSS: 16.15 (-0.14), ARRY: 8.05 (+0.08), INFN: 17.56 (-0.10), LF: 2.51 (+0.06)

Uroplasty FQ3 revenues up 5%
Seeking Alpha - at Seeking Alpha - Fri Jan 23, 5:39AM CST

UPI: 1.27 (unch)

Uroplasty's (UPI) CEO Robert Kill on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 22, 8:41PM CST

UPI: 1.27 (unch)

Uroplasty (UPI) Q3 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Jan 22, 3:25PM CST

UPI: 1.27 (unch)

Uroplasty misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Jan 22, 3:03PM CST

UPI: 1.27 (unch)

Uroplasty Reports Record Revenue in Fiscal Third Quarter
PR Newswire - Thu Jan 22, 3:01PM CST
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 third quarter ended December 31, 2014.
UPI: 1.27 (unch)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Uroplasty, Inc. of Class Action Challenging the Fairness of the Sale of the Company to Vision-Sciences, Inc. -- UPI
GlobeNewswire - Fri Jan 16, 8:58AM CST
Levi & Korsinsky notifies shareholders of Uroplasty, Inc. ("Uroplasty" or "the Company"

(Nasdaq:UPI) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Vision-Sciences, Inc. (Nasdaq:VSCI). A complaint was filed in Minnesota state court.
VSCI: 0.47 (unch), UPI: 1.27 (unch)

Uroplasty To Announce Third Quarter Fiscal Year 2015 Financial Results On January 22, 2015
PR Newswire - Wed Jan 14, 6:00AM CST
Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the fiscal third quarter ended December 31, 2014 after the market close on Thursday, January 22, 2015.
UPI: 1.27 (unch)

UPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc. - UPI
Business Wire - Wed Dec 31, 11:33AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Uroplasty, Inc. (NasdaqCM:UPI) ("Uroplasty"

in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM:VSCI).
VSCI: 0.47 (unch), UPI: 1.27 (unch)

Lifshitz & Miller Law Firm Announces Investigation of Caesars Acquisition Company, Imperial Holdings, Inc., Peerless Systems Corporation, Roka Bioscience, Inc., RCS Capital Corporation and Uroplasty, Inc.
PR Newswire - Tue Dec 30, 10:59AM CST
Caesars Acquisition Company
CACQ: 7.72 (+0.12), ROKA: 4.04 (+0.01), RCAP: 10.28 (+0.28), PRLS: 6.96 (-0.02), UPI: 1.27 (unch), ARCP: 9.40 (+0.06), CZR: 10.78 (+0.18), IFT: 6.41 (+0.04)

Hidden Annualized 66% Return: Uroplasty Inc. And Vision-Sciences To Merge
Maudes Capital - at Seeking Alpha - Mon Dec 29, 12:52PM CST

VSCI: 0.47 (unch), UPI: 1.27 (unch)

Merger Arbitrage Mondays - December 29, 2014
Asif Suria - at Seeking Alpha - Mon Dec 29, 10:06AM CST
Merger activity decreased last week with three new mergers announced and three deals closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal Statistics: ...
CACQ: 7.72 (+0.12), PIKE: 12.01 (+0.01), PRLS: 6.96 (-0.02), MGAM: 36.44 (-0.01), VSCI: 0.47 (unch), UPI: 1.27 (unch), CZR: 10.78 (+0.18), OPLK: 24.23 (-0.03), GCA: 6.92 (+0.17)

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc.
Business Wire - Wed Dec 24, 11:19AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company"

(NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.47 (unch), UPI: 1.27 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WIN Expands Leadership Amidst Rapid Growth Surge

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

JiMMYBAR! Unveils World's First Creatine Trail Mix

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Vayo Debuts as Booking Holdings Eyes $100M Investment

A travel revolution might just be on the horizon, courtesy of Booking Holdings' latest venture, Vayo. And they’re talking about throwing $100 million into it—subject to a few conditions, sure—but that’s not pocket change you toss around without a serious plan. Transforming Travel into a Seamless Experience Vayo’s got one job: making your travels less like a...

Marshall Goldman Expands Footprint with Marino Acquisition

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Jaguar Promise Tackles College Cost for Texas Students

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Puori Protein Transparency Pays Off Amid Lead Scare

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Wagner Logistics Gears Up for Major Expansion in Liberty

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

xFusion Tackles Cooling and Power at OCP 2026

Bracing for an AI Revolution Ah, the world of AI — it's like the wild west out there, with data centers struggling to keep up as workloads skyrocket. Enter xFusion, a veteran in the computing infrastructure game, rolling out some seriously impressive tech at the 2026 Open Compute Project (OCP) Global Summit. The company's latest offering showcases how they're tackling...

FCS Drives Key FDA Approvals in Cancer Treatment

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Tessa AI: Revolutionizing Biomedical Research with AI

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...